Reply to S. Sorscher.

James Hadfield Chris Abbosh Darren Hodgson Dan Stetson

J Clin Oncol

James Hadfield, PhD, Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom; Chris Abbosh, MD, PhD, Cancer Biomarker Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom, Saga Diagnostics, Lund, Sweden; Darren Hodgson, PhD, Cancer Biomarker Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom; and Dan Stetson, MS, Translational Medicine, Oncology R&D, AstraZeneca, Waltham, MA.

Published: November 2024

Download full-text PDF	Source
http://dx.doi.org/10.1200/JCO-24-01599	DOI Listing

Publication Analysis

Top Keywords

reply sorscher

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!